• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

First-Time Generics - February 2009

 Generic Drug NameGeneric ManufacturerBrand NameApproval Date
1MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE TABLETS, 45 MG (BASE), 90 MG (BASE) AND 135 MG (BASE)     IMPAX LABORATORIES, INC.SOLODYN TABLETS2/3/2009 
2SUMATRIPTAN SUCCINATE INJECTION, 4 MG (BASE)/0.5 ML AND 6 MG (BASE)/0.5 ML; SINGLE-DOSE VIALS     SANDOZ CANADA, INC.IMITREX INJECTION, SINGLE DOSE VIALS2/6/2009 
3SUMATRIPTAN SUCCINATE INJECTION, 6 MG (BASE)/0.5 ML; SINGLE-DOSE VIALS      BEDFORD LABORATORIESIMITREX INJECTION, 6 MG (BASE)/0.5 ML2/6/2009 
4SUMATRIPTAN SUCCINATE INJECTION, 6 MG (BASE)/0.5 ML; SINGLE-DOSE VIALS      TEVA PARENTERAL MEDICINESIMITREX INJECTION, 6 MG (BASE)/0.5 ML2/6/2009 
5SUMATRIPTAN SUCCINATE INJECTION (SYRINGE), 4 MG (BASE)/0.5 ML AND 6 MG (BASE)/0.5 ML; PRE-FILLED SYRINGES     TEVA PARENTERAL MEDICINESIMITREX INJECTION, 8 MG/ML, 12 MG/ML SYRINGE2/6/2009 
6SUMATRIPTAN SUCCINATE TABLETS, 25 MG (BASE), 50 MG (BASE) AND 100 MG (BASE)     TEVA PHARMACEUTICALS USAIMITREX TABLETS2/9/2009 
7SUMATRIPTAN SUCCINATE TABLETS, 100 MG       RANBAXY LABORATORIES LIMITEDIMITREX TABLETS2/9/2009 
8RISPERIDONE ORALLY DISINTEGRATING TABLETS, 0.5 MG AND 2 MG      DR. REDDY'S LABORATORIES LIMITEDRISPERDAL M-TAB (ORALLY DISINTEGRATING TABLET2/24/2009